Table 3.

Evidence-based recommendations for use of progesterone in assisted reproductive technology (ART).

Evidence-based recommendations
Luteal phase support should be provided for intrauterine insemination with oral dydrogesterone (10 mg, three times daily) or vaginal micronized progesterone (200 mg, three times daily), depending on patient preference [2,59,76]